Difference in the Dynamics of Antibody Titer between COVID-19 Vaccination and SARS-CoV-2 Infection in Healthcare Workers –A Case Study Based on Long-Term and Dense Measurement of Antibody Titer

Durability and breadth of neutralisation following multiple antigen exposures to SARS-CoV-2 infection and/or COVID-19 vaccination

(2023) Alexander P. Underwood et al.   EBioMedicine

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

(2022) Alasdair P S Munro et al.   LANCET INFECTIOUS DISEASES

Evolution of antibody immunity to SARS-CoV-2

(2021) Christian Gaebler et al.   NATURE

Neutralizing antibody titres in SARS-CoV-2 infections

(2021) Eric H. Y. Lau et al.   Nature Communications

Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination

(2021) Venkata Viswanadh Edara et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

(2021) David S. Khoury et al.   NATURE MEDICINE

COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants

(2021) Pinja Jalkanen et al.   Nature Communications

Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study

(2021) Wan Ni Chia et al.   Lancet Microbe

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months

(2021) Einav G. Levin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE